Moderna Inc (0QF)

TradeGate
Currency in EUR
Disclaimer
137.00
-3.94
(-2.80%)
Delayed Data
Day's Range
136.92
140.98
52 wk Range
111.00
203.30
Volume
3,688
Prev. Close
140.94
Open
140.26
Day's Range
136.92-140.98
52 wk Range
111-203.3
Volume
3,688
Average Volume (3m)
6,678
1-Year Change
-6.74%
Shares Outstanding
385,677,955
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
226.64
Upside +53.60%

People Also Watch

29.36
INTC
+1.14%
27.14
BAC
+0.63%
267.79
NVDA
-1.52%
152.65
JNJ
+1.01%
124.91
JPM
-1.52%

Moderna Inc News

Moderna Inc Analysis

Moderna Inc Company Profile

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.